vs
Acadia Healthcare Company, Inc.（ACHC）与CoStar Group（CSGP）财务数据对比。点击上方公司名可切换其他公司
CoStar Group的季度营收约是Acadia Healthcare Company, Inc.的1.1倍（$899.9M vs $829.0M），CoStar Group净利率更高（5.2% vs 0.5%，领先4.6%），CoStar Group同比增速更快（26.9% vs 7.5%），过去两年CoStar Group的营收复合增速更高（17.1% vs 2.0%）
阿卡迪亚医疗公司是美国的营利性行为医疗健康服务提供商，目前在美国及波多黎各地区运营着超过225家医疗机构，搭建了覆盖广泛的行为健康服务网络，为有相关需求的人群提供专业的心理健康与行为干预服务。
CoStar Group是1987年成立的美国商业地产服务商，总部位于弗吉尼亚州阿灵顿，业务覆盖北美、欧洲地区，为商业地产行业提供信息、分析及营销解决方案，旗下运营CoStar线上数据库、新闻网站及Apartments.com、Homes.com等多个线上平台。
ACHC vs CSGP — 直观对比
营收规模更大
CSGP
是对方的1.1倍
$829.0M
营收增速更快
CSGP
高出19.3%
7.5%
净利率更高
CSGP
高出4.6%
0.5%
两年增速更快
CSGP
近两年复合增速
2.0%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $829.0M | $899.9M |
| 净利润 | $4.5M | $46.5M |
| 毛利率 | — | 78.6% |
| 营业利润率 | — | 5.5% |
| 净利率 | 0.5% | 5.2% |
| 营收同比 | 7.5% | 26.9% |
| 净利润同比 | -50.8% | -22.2% |
| 每股收益（稀释后） | $0.05 | $0.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACHCCSGP
| Q1 26 | $829.0M | — | ||
| Q4 25 | $821.5M | $899.9M | ||
| Q3 25 | $851.6M | $833.6M | ||
| Q2 25 | $869.2M | $781.3M | ||
| Q1 25 | $770.5M | $732.2M | ||
| Q4 24 | $774.2M | $709.4M | ||
| Q3 24 | $815.6M | $692.6M | ||
| Q2 24 | $796.0M | $677.8M |
净利润ACHCCSGP
| Q1 26 | $4.5M | — | ||
| Q4 25 | $-1.2B | $46.5M | ||
| Q3 25 | $36.2M | $-30.9M | ||
| Q2 25 | $30.1M | $6.2M | ||
| Q1 25 | $8.4M | $-14.8M | ||
| Q4 24 | $32.6M | $59.8M | ||
| Q3 24 | $68.1M | $53.0M | ||
| Q2 24 | $78.5M | $19.2M |
毛利率ACHCCSGP
| Q1 26 | — | — | ||
| Q4 25 | — | 78.6% | ||
| Q3 25 | — | 79.3% | ||
| Q2 25 | — | 78.5% | ||
| Q1 25 | — | 79.1% | ||
| Q4 24 | — | 80.1% | ||
| Q3 24 | — | 79.7% | ||
| Q2 24 | — | 80.0% |
营业利润率ACHCCSGP
| Q1 26 | — | — | ||
| Q4 25 | -142.4% | 5.5% | ||
| Q3 25 | 4.7% | -6.1% | ||
| Q2 25 | 5.8% | -3.5% | ||
| Q1 25 | 1.7% | -5.8% | ||
| Q4 24 | 4.9% | 5.6% | ||
| Q3 24 | 12.1% | 3.4% | ||
| Q2 24 | 13.4% | -2.4% |
净利率ACHCCSGP
| Q1 26 | 0.5% | — | ||
| Q4 25 | -143.3% | 5.2% | ||
| Q3 25 | 4.3% | -3.7% | ||
| Q2 25 | 3.5% | 0.8% | ||
| Q1 25 | 1.1% | -2.0% | ||
| Q4 24 | 4.2% | 8.4% | ||
| Q3 24 | 8.4% | 7.7% | ||
| Q2 24 | 9.9% | 2.8% |
每股收益（稀释后）ACHCCSGP
| Q1 26 | $0.05 | — | ||
| Q4 25 | $-12.98 | $0.12 | ||
| Q3 25 | $0.40 | $-0.07 | ||
| Q2 25 | $0.33 | $0.01 | ||
| Q1 25 | $0.09 | $-0.04 | ||
| Q4 24 | $0.36 | $0.14 | ||
| Q3 24 | $0.74 | $0.13 | ||
| Q2 24 | $0.85 | $0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $158.5M | $1.6B |
| 总债务越低越好 | $2.5B | $140.0M |
| 股东权益账面价值 | $2.0B | $8.3B |
| 总资产 | $5.5B | $10.5B |
| 负债/权益比越低杠杆越低 | 1.29× | 0.02× |
8季度趋势，按日历期对齐
现金及短期投资ACHCCSGP
| Q1 26 | $158.5M | — | ||
| Q4 25 | $133.2M | $1.6B | ||
| Q3 25 | $118.7M | $1.9B | ||
| Q2 25 | $131.4M | $3.6B | ||
| Q1 25 | $91.2M | $3.7B | ||
| Q4 24 | $76.3M | $4.7B | ||
| Q3 24 | $82.1M | — | ||
| Q2 24 | $77.2M | — |
总债务ACHCCSGP
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | $140.0M | ||
| Q3 25 | $2.3B | $1.0B | ||
| Q2 25 | $2.3B | $1.0B | ||
| Q1 25 | $2.2B | $1.0B | ||
| Q4 24 | $2.0B | $1.0B | ||
| Q3 24 | $1.9B | $1.0B | ||
| Q2 24 | $1.8B | $1.0B |
股东权益ACHCCSGP
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.9B | $8.3B | ||
| Q3 25 | $3.1B | $8.6B | ||
| Q2 25 | $3.1B | $8.6B | ||
| Q1 25 | $3.0B | $8.6B | ||
| Q4 24 | $3.1B | $7.6B | ||
| Q3 24 | $3.0B | $7.5B | ||
| Q2 24 | $3.0B | $7.4B |
总资产ACHCCSGP
| Q1 26 | $5.5B | — | ||
| Q4 25 | $5.5B | $10.5B | ||
| Q3 25 | $6.4B | $10.8B | ||
| Q2 25 | $6.3B | $10.5B | ||
| Q1 25 | $6.1B | $10.4B | ||
| Q4 24 | $6.0B | $9.3B | ||
| Q3 24 | $5.9B | $9.1B | ||
| Q2 24 | $5.7B | $9.1B |
负债/权益比ACHCCSGP
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | 0.02× | ||
| Q3 25 | 0.74× | 0.12× | ||
| Q2 25 | 0.74× | 0.12× | ||
| Q1 25 | 0.72× | 0.12× | ||
| Q4 24 | 0.64× | 0.13× | ||
| Q3 24 | 0.62× | 0.13× | ||
| Q2 24 | 0.62× | 0.14× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $61.5M | $162.1M |
| 自由现金流经营现金流 - 资本支出 | — | $101.3M |
| 自由现金流率自由现金流/营收 | — | 11.3% |
| 资本支出强度资本支出/营收 | — | 6.8% |
| 现金转化率经营现金流/净利润 | 13.78× | 3.49× |
| 过去12个月自由现金流最近4个季度 | — | $123.0M |
8季度趋势，按日历期对齐
经营现金流ACHCCSGP
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $162.1M | ||
| Q3 25 | $73.2M | $68.2M | ||
| Q2 25 | $133.5M | $146.5M | ||
| Q1 25 | $11.5M | $53.2M | ||
| Q4 24 | $116.7M | $94.6M | ||
| Q3 24 | $163.1M | $100.3M | ||
| Q2 24 | $171.1M | $58.1M |
自由现金流ACHCCSGP
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | $101.3M | ||
| Q3 25 | $-63.0M | $-5.5M | ||
| Q2 25 | $-34.2M | $27.7M | ||
| Q1 25 | $-163.2M | $-500.0K | ||
| Q4 24 | $-86.8M | $25.2M | ||
| Q3 24 | $-27.1M | $40.2M | ||
| Q2 24 | $16.9M | $-14.7M |
自由现金流率ACHCCSGP
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | 11.3% | ||
| Q3 25 | -7.4% | -0.7% | ||
| Q2 25 | -3.9% | 3.5% | ||
| Q1 25 | -21.2% | -0.1% | ||
| Q4 24 | -11.2% | 3.6% | ||
| Q3 24 | -3.3% | 5.8% | ||
| Q2 24 | 2.1% | -2.2% |
资本支出强度ACHCCSGP
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | 6.8% | ||
| Q3 25 | 16.0% | 8.8% | ||
| Q2 25 | 19.3% | 15.2% | ||
| Q1 25 | 22.7% | 7.3% | ||
| Q4 24 | 26.3% | 9.8% | ||
| Q3 24 | 23.3% | 8.7% | ||
| Q2 24 | 19.4% | 10.7% |
现金转化率ACHCCSGP
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | 3.49× | ||
| Q3 25 | 2.02× | — | ||
| Q2 25 | 4.43× | 23.63× | ||
| Q1 25 | 1.37× | — | ||
| Q4 24 | 3.58× | 1.58× | ||
| Q3 24 | 2.39× | 1.89× | ||
| Q2 24 | 2.18× | 3.03× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
CSGP
| Co Star | $503.8M | 56% |
| Other | $283.0M | 31% |
| Loop Net | $94.7M | 11% |
